Secondary Hemophagocytic Syndrome Associated with Herpes Virus Infections
https://doi.org/10.22627/2072-8107-2015-14-4-64-67
Abstract
Hemophagocytic syndrome is one of the complications of herpes virus infections. Here, we describe the case of a 8—year-old male with secondary hemophagocytic syndrome. The disease was diagnosed in the early stages. The patient received treatment with dexamethasone, intravenous immunoglobulin, which has led to a weakening of the ignition and the suppression of the disease with rapid treatment.
About the Authors
S. R. Rodionovskaya
Central Children's Clinical Hospital of the Federal Medical-Biological Agency of Russia
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation
Russian Federation
Russian Federation
CMS, Head of the Department of Rheumatology, of Central Children's Clinical Hospital of the Federal Medical-Biological Agency of Russia, Senior Researcher, the Laboratory of Rheumatic Diseases of Childhood with the Rehabilitation Group, V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences; Russian Federation, 115409, 20, Moskvorechye, st., Moscow; tel. (499) 324-96-58
I. B. Alakaeva
Central Children's Clinical Hospital of the Federal Medical-Biological Agency of Russia
Russian Federation
Russian Federation
I. N. Tsymbal
Central Children's Clinical Hospital of the Federal Medical-Biological Agency of Russia
Russian Federation
Russian Federation
References
1. Масчан М.А., Полтавец Н.В. Гемофагоцитарный синдром в неотложной педиатрии // Педиатрическая фармакология. 2011. Т. 8 № 2. С. 15—21. Maschan M.A., Poltavets N.V. [Hemophagocytic syndrome in emergency and intensive pediatrics] // Pediatric Pharmacology. 2011. T. 8, № 2. S. 15—21. (In Russ).
2. Jordan M.B., Allen C.E., Weitzman S., Filipovich A.H., McClain K.L. [How I treat hemophagocytic lymphohistiocytosis] // Blood. 2011. 13, № 118(15). P. 4041—52.
3. Fisman D.N. [Hemophagocytic syndromes and infection] // Emerg Infect Dis. 2000. № 6(6). P. 601—8.
4. Fox C.P., Shannon-Lowe C., Gothard P., Kishore B., Neilson J., O'Connor N., Rowe M. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral geno me load within circulating natural killer cells] // Clin Infect Dis. 2010. 1, № 51. P. 66—9.
5. Анохин В.А., Фаткуллина Р.Г., Акчурина Л.Б. Гемофагоцитарный синдром и герпесвирусные инфекции // Инфектология. 2012. Т 4, №1. c. 81—84. Anohin V.A., Fatkullina R.G., Akchurina L.B. [Hemophagocytic syndrome and herpes virus infections] // Jurnal Infektologii. 2012. T. 4, № 1. S. 81—84. (In Russ).
6. Marsh R., Madden L., Kitchen B., Mody R., McClimon B., Jordan M. B., et al. [XIAP deficiency: a unique primary immunodeficiency best classi fied as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease] // Blood. 2010. 116(7). P. 1079—1082.
7. Kasahara Y., Yachie A., Takei K., Kanegane C., Okada K., Ohta K., et al. [Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection] // Blood. 2001. 15, 98(6). P. 1882—8.
8. Henter J.I., Horne A., Aricó M., Egeler R.M., Filipovich A.H., Imashuku S., et. al. [HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis] // Pediatr Blood Cancer. 2007. №48(2). P. 124—31.
9. Imashuku S., Tabata Y., Teramura T., et al. [Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH)] // Leuk Lymphoma. 2000. №39. P. 37—49.
10. Imashuku S., Kuriyama K., Teramura T., Kinugawa N., Kato M., Sako M., et al. [Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis] // J Clin Oncol. 2001. №19. P. 2665—73.
11. Balamuth N.J., Nichols K.E., Paessler M., Teachey D.T. [Use of rituximab in cinjunction with immunosuppressive chemotherapy for EBVassociated hemophagocytic lymphohistiocytosis] // J. Pediatr. Hematol. Oncol. 2007. № 29(8). P. 569—73.
12. Chellapandian D., Das R., Zelley K., Wiener S.J., Zhao H., Teachey D.T., et al. [Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens] // Br. J. Haematol. 2013. №8,162(3). P. 376—82.
13. Goudarzipour K., Kajiyazdi M., Mahdaviyani A. [Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis] // International Journal of Hematology-Oncology and Stem Cell Research. 2013. № 7(1). P. 42—45.
14. Emmenegger U., Frey U, Reimers A. [Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes] // Am J Hematol. 2001. № 68. P. 4—10.
Review
For citations:
Rodionovskaya S.R., Alakaeva I.B., Tsymbal I.N. Secondary Hemophagocytic Syndrome Associated with Herpes Virus Infections. CHILDREN INFECTIONS. 2015;14(4):64-67. (In Russ.) https://doi.org/10.22627/2072-8107-2015-14-4-64-67
Views:
1304
Email this article 